Adenovirus Targeting Small Molecule
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
310
NCT05586152
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 30, 2022
Completion: May 2, 2023
NCT05636228
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Phase: Phase 2
Start: Jun 9, 2023
Completion: Aug 22, 2024
NCT06370039
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Start: Mar 27, 2024
Completion: Jul 3, 2024
NCT06599684
Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Start: Sep 7, 2024
Completion: Aug 31, 2025
Loading map...